Navigation Links
New Leadership Team at International Trachoma Initiative to Build Stronger Partnerships to Eliminate Blinding Trachoma
Date:7/1/2009

Priority is collaborating effectively with government and NGO partners and strengthening the supply chain for delivering Pfizer-donated Zithromax

ATLANTA, July 1 /PRNewswire-USNewswire/ -- The International Trachoma Initiative (ITI) has a new leadership team focused on creating effective collaborations among governments and NGOs in 56 trachoma endemic countries. Through stronger partnerships, ITI hopes to support local, national, regional, and international groups in reaching the goal of eliminating blinding trachoma globally by 2020. The leadership team has extensive experience in trachoma programming and addressing Neglected Tropical Diseases (NTDs).

"We see ITI as a partner among partners in the global trachoma community," said Dr. Danny Haddad, ITI Director. "Governments and NGOs are committed to implementing the SAFE strategy -- Surgery, Antibiotics, Facial cleanliness, and Environmental improvements -- used to treat and prevent trachoma. We are setting up a Trachoma Expert Committee with experts in water, sanitation, health communications and surgery."

When ITI merged with the Task Force for Global Health in April 2009, Jeffrey B. Kindler, the Chairman and CEO of Pfizer, which supplies the antibiotic Zithromax that treats and prevents trachoma, stated, "We look forward to continuing our support and working through ITI and its Trachoma Expert Committee to provide the Zithromax that will be needed to eliminate blinding trachoma by 2020 and restore the health and well-being of families now and generations to come."

"The Zithromax drug donation program remains the key priority," said Haddad. "With this renewed commitment from Pfizer, our top goal is to make sure that Zithromax is distributed on time and in the right quantity to our partner countries."

Dr. Haddad is joined by four key staff members:

  • Associate Director Lisa Rotondo has extensive public health program management and evaluation experience, with an emphasis on trachoma and other NTDs in Africa.
  • Supply Chain Manager Vivian Singletary has worked over 15 years on managing supply chain optimization projects, including mid- to long-term strategy, IT system implementations and process improvement.
  • Project Manger PJ Hooper, who oversees a Gates Foundation grant supporting NTD integration research, has conducted operational research on Lymphatic Filariasis and NTDs for another Gates grant to the Global Alliance to Eliminate LF.
  • Program Accounting Manager Edward Nyankson has 16 years experience in accounting and financial reporting, tax, securities exchange and regulatory reporting.

ITI has program offices in Ethiopia, Ghana, Mali, Niger, Tanzania and Vietnam.

www.trachoma.org


'/>"/>
SOURCE The International Trachoma Initiative (ITI)
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. N.C. Takes Biofuels Leadership, Establishes New Endeavor With $5 Million State Appropriation
2. Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry
3. KGI and Smith College Establish Leadership Forum for Women in Bioscience
4. Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference
5. Assay Designs(TM) Announces Additions to the Leadership Team
6. Deloitte Leadership Offers Crucial Convergence Considerations for Life Sciences Companies
7. Dr. Dinesh Verma to be honored with Presidents Leadership Award at Edwin A. Stevens Society Gala
8. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
9. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
10. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
11. Halogen Announces Record Year - Company Solidifies Leadership Position, Secures Strategic Wins Over Competition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 AskLinkerReports.com has published a report ... Amyloglucosidase Industry 2016 Market Research Report. From a basic outline ... overview are all covered in the report. This report projects ... analysis of the Amyloglucosidase industry. ... , , ...
(Date:12/8/2016)... , Dec. 8, 2016  Renova™ Therapeutics, ... congestive heart failure and type 2 diabetes, announced ... a novel adeno-associated virus (AAV) vector developed in ... M.D., Ph.D., at Stanford University. The company plans ... paracrine gene therapy product pipeline. ...
(Date:12/8/2016)... CARDIFF, UK (PRWEB) , ... December 08, 2016 ... ... high precision light to control cells — optogenetics — is key to exciting ... state of the art, spatially patterned light projected via free-space optics stimulates small, ...
(Date:12/8/2016)... 2016 Oxford Gene ... seine Palette an anpassbaren SureSeq™ NGS-Panels mit dem ... das ein schnelles und kostengünstiges Studium der Varianten ... eine Erkennung von Einzel-Nukleotid-Variationen (Single Nucleotide Variation, SNV) ... kleinen Panel und ermöglicht eine individuelle Anpassung durch ...
Breaking Biology Technology:
(Date:11/28/2016)... "The biometric system market projected to ... system market is in the growth stage and is ... biometric system market is expected to be valued at ... 16.79% between 2016 and 2022. Government initiative in adoption ... rising use of biometric technology in financial institutes and ...
(Date:11/22/2016)... , Nov. 22, 2016   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... Medical LiveWire Healthcare and Life Sciences Awards as ... caps off an unprecedented year of recognition and growth ... for over 15 years. iMedNet ...
(Date:11/17/2016)... Global Market Watch: Primarily supported by ... Banks and Academics) market is to witness a value of ... the highest Compounded Annual Growth Rate (CAGR) of 10.75% is ... analysis period 2014-2020. North America is ... Europe at 9.56% respectively. Report ...
Breaking Biology News(10 mins):